SciELO - Scientific Electronic Library Online

 
vol.12 número3Alteraciones ecocardiográficas precoces en la enfermedad de Chagas crónica sin patología demostradaTerapia de resincronización cardíaca en la enfermedad de Chagas índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Insuficiencia cardíaca

versión On-line ISSN 1852-3862

Resumen

GUTIERREZ PERUCHO¹, Ernesto. Ablación por radiofrecuencia de arritmias por miocardiopatía chagásica. Insuf. card. [online]. 2017, vol.12, n.3, pp.111-114. ISSN 1852-3862.

It is estimated that in patients infected with the parasite Trypanosoma cruzi, 20 to 30% develop myocardial damage (1- 1.2 million in Latin America). Of these, up to 65% may present sudden death without therapeutic intervention. Carlos Chagas himself described this complication 10 years after its discovery. Cardiac arrhythmias, observed mainly in the chronic phase, are benign (isolated monomorphic extrasystoles) when the myocardium is stable, and in its destabilization can develop sustained ventricular tachycardia and ventricular fibrillation. Therapeutic intervention in this type of arrhythmia has been shown to substantially reduce the mortality of this pathology, including pharmacological treatment (amiodarone), implantation of an implantable cardioverter defibrillator (ICD) and radiofrequency ablation (RFA) with an endocardial and epicardial catheter. In studies carried out in Mexico, up to 76% of patients seropositive for Chagas’ disease have developed arrhythmias (48% ventricular and 28% supraventricular). It is noteworthy that 66% of these cases present electrocardiographic signs of subepicardial ischemia. The experience with RFA in arrhythmias due to chagasic cardiomyopathy has already been 20 years, the application of this technique with epicardial approach was initiated in patients with chagasic etiology. The initial successful results of up to 40% have been improved with the new techniques of electroanatomic mapping. Recently, papers have been published that support the utility of RFA to prevent the number of implants and therapies applied with ICDs. It should be noted that the deleterious effect on the ventricular function of RFA has been documented, especially in patients with low ejection fraction.

Palabras clave : Arrhythmias in Chagas’ disease; Radiofrequency ablation; Chagasic cardiomyopathy; Amiodarone; Implantable cardioverter defibrillator.

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons